These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 26033831)

  • 1. Evaluation of (4-Arylpiperidin-1-yl)cyclopentanecarboxamides As High-Affinity and Long-Residence-Time Antagonists for the CCR2 Receptor.
    Vilums M; Zweemer AJ; Dilanchian A; van Veldhoven JP; de Vries H; Brussee J; Saunders J; Stamos D; Heitman LH; IJzerman AP
    ChemMedChem; 2015 Jul; 10(7):1249-58. PubMed ID: 26033831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. When structure-affinity relationships meet structure-kinetics relationships: 3-((Inden-1-yl)amino)-1-isopropyl-cyclopentane-1-carboxamides as CCR2 antagonists.
    Vilums M; Zweemer AJ; Barmare F; van der Gracht AM; Bleeker DC; Yu Z; de Vries H; Gross R; Clemens J; Krenitsky P; Brussee J; Stamos D; Saunders J; Heitman LH; IJzerman AP
    Eur J Med Chem; 2015 Mar; 93():121-34. PubMed ID: 25666912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-kinetic relationships--an overlooked parameter in hit-to-lead optimization: a case of cyclopentylamines as chemokine receptor 2 antagonists.
    Vilums M; Zweemer AJ; Yu Z; de Vries H; Hillger JM; Wapenaar H; Bollen IA; Barmare F; Gross R; Clemens J; Krenitsky P; Brussee J; Stamos D; Saunders J; Heitman LH; Ijzerman AP
    J Med Chem; 2013 Oct; 56(19):7706-14. PubMed ID: 24028535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and evaluation of cis-3,4-disubstituted piperidines as potent CC chemokine receptor 2 (CCR2) antagonists.
    Cherney RJ; Nelson DJ; Lo YC; Yang G; Scherle PA; Jezak H; Solomon KA; Carter PH; Decicco CP
    Bioorg Med Chem Lett; 2008 Sep; 18(18):5063-5. PubMed ID: 18722120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of 3-piperidinyl-1-cyclopentanecarboxamide as a novel scaffold for highly potent CC chemokine receptor 2 antagonists.
    Yang L; Butora G; Jiao RX; Pasternak A; Zhou C; Parsons WH; Mills SG; Vicario PP; Ayala JM; Cascieri MA; MacCoss M
    J Med Chem; 2007 May; 50(11):2609-11. PubMed ID: 17461566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery and SAR of 5-aminooctahydrocyclopentapyrrole-3a-carboxamides as potent CCR2 antagonists.
    Cai C; McComsey DF; Hou C; O'Neill JC; Opas E; McKenney S; Johnson D; Sui Z
    Bioorg Med Chem Lett; 2014 Feb; 24(4):1239-42. PubMed ID: 23916257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and synthesis of novel small molecule CCR2 antagonists: evaluation of 4-aminopiperidine derivatives.
    Vilums M; Zweemer AJ; Dekkers S; Askar Y; de Vries H; Saunders J; Stamos D; Brussee J; Heitman LH; IJzerman AP
    Bioorg Med Chem Lett; 2014 Dec; 24(23):5377-80. PubMed ID: 25453791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conformational studies of 3-amino-1-alkyl-cyclopentane carboxamide CCR2 antagonists leading to new spirocyclic antagonists.
    Pasternak A; Goble SD; Doss GA; Tsou NN; Butora G; Vicario PP; Ayala JM; Struthers M; Demartino JA; Mills SG; Yang L
    Bioorg Med Chem Lett; 2008 Feb; 18(4):1374-7. PubMed ID: 18215519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Capped diaminopropionamide-glycine dipeptides are inhibitors of CC chemokine receptor 2 (CCR2).
    Carter PH; Brown GD; Friedrich SR; Cherney RJ; Tebben AJ; Lo YC; Yang G; Jezak H; Solomon KA; Scherle PA; Decicco CP
    Bioorg Med Chem Lett; 2007 Oct; 17(19):5455-61. PubMed ID: 17720492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological evaluation of spirocyclic antagonists of CCR2 (chemokine CC receptor subtype 2).
    Strunz AK; Zweemer AJ; Weiss C; Schepmann D; Junker A; Heitman LH; Koch M; Wünsch B
    Bioorg Med Chem; 2015 Jul; 23(14):4034-49. PubMed ID: 25766632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probing the structural and topological requirements for CCR2 antagonism: holographic QSAR for indolopiperidine derivatives.
    Srikanth K; Nair PC; Sobhia ME
    Bioorg Med Chem Lett; 2008 Feb; 18(4):1450-6. PubMed ID: 18226895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, structure-activity relationship and in vivo antiinflammatory efficacy of substituted dipiperidines as CCR2 antagonists.
    Xia M; Hou C; DeMong DE; Pollack SR; Pan M; Brackley JA; Jain N; Gerchak C; Singer M; Malaviya R; Matheis M; Olini G; Cavender D; Wachter M
    J Med Chem; 2007 Nov; 50(23):5561-3. PubMed ID: 17929797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological evaluation of phenyl piperidine derivatives as CCR2 antagonists.
    Xia M; Hou C; Pollack S; Brackley J; DeMong D; Pan M; Singer M; Matheis M; Olini G; Cavender D; Wachter M
    Bioorg Med Chem Lett; 2007 Nov; 17(21):5964-8. PubMed ID: 17869105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potent heteroarylpiperidine and carboxyphenylpiperidine 1-alkyl-cyclopentane carboxamide CCR2 antagonists.
    Pasternak A; Goble SD; Vicario PP; Di Salvo J; Ayala JM; Struthers M; DeMartino JA; Mills SG; Yang L
    Bioorg Med Chem Lett; 2008 Feb; 18(3):994-8. PubMed ID: 18164199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substituted dipiperidine alcohols as potent CCR2 antagonists.
    Xia M; Hou C; Demong D; Pollack S; Pan M; Brackley J; Singer M; Matheis M; Cavender D; Wachter M
    Bioorg Med Chem Lett; 2008 Jun; 18(12):3562-4. PubMed ID: 18487045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel, orally bioavailable gamma-aminoamide CC chemokine receptor 2 (CCR2) antagonists.
    Pasternak A; Marino D; Vicario PP; Ayala JM; Cascierri MA; Parsons W; Mills SG; Maccoss M; Yang L
    J Med Chem; 2006 Aug; 49(16):4801-4. PubMed ID: 16884289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple binding sites for small-molecule antagonists at the CC chemokine receptor 2.
    Zweemer AJ; Nederpelt I; Vrieling H; Hafith S; Doornbos ML; de Vries H; Abt J; Gross R; Stamos D; Saunders J; Smit MJ; Ijzerman AP; Heitman LH
    Mol Pharmacol; 2013 Oct; 84(4):551-61. PubMed ID: 23877010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, binding affinity and structure-activity relationships of novel, selective and dual targeting CCR2 and CCR5 receptor antagonists.
    Junker A; Kokornaczyk AK; Zweemer AJ; Frehland B; Schepmann D; Yamaguchi J; Itami K; Faust A; Hermann S; Wagner S; Schäfers M; Koch M; Weiss C; Heitman LH; Kopka K; Wünsch B
    Org Biomol Chem; 2015 Feb; 13(8):2407-22. PubMed ID: 25566983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and structure-activity relationship of 7-azaindole piperidine derivatives as CCR2 antagonists.
    Xia M; Hou C; DeMong D; Pollack S; Pan M; Singer M; Matheis M; Murray W; Cavender D; Wachter M
    Bioorg Med Chem Lett; 2008 Dec; 18(24):6468-70. PubMed ID: 18990568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of trisubstituted cyclohexanes as potent CC chemokine receptor 2 (CCR2) antagonists.
    Cherney RJ; Brogan JB; Mo R; Lo YC; Yang G; Miller PB; Scherle PA; Molino BF; Carter PH; Decicco CP
    Bioorg Med Chem Lett; 2009 Feb; 19(3):597-601. PubMed ID: 19131247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.